Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by PSYENCE BIOMEDICAL LTD.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
EFFECT | Document | Acc-no: 9999999995-24-001524 (33 Act) Size: 1 KB | May-14-2024 | 24946868 |
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001410578-24-000708 (33 Act) Size: 9809 KB |
May-10-2024 | 24932180 |
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001410578-24-000598 (33 Act) Size: 9790 KB |
May-07-2024 | 24919248 |
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001410578-24-000510 (33 Act) Size: 10047 KB |
Apr-18-2024 | 24852712 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-24-035072 (34 Act) Size: 25 KB |
Mar-15-2024 | 24755874 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-24-033543 (34 Act) Size: 5613 KB |
Mar-12-2024 | 24743491 |
F-1 | Document | Registration statement for securities of certain foreign private issuers Acc-no: 0001104659-24-012923 (33 Act) Size: 2287 KB |
Feb-09-2024 | 24614927 |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-24-010648 (34 Act) Size: 42 KB |
Feb-05-2024 | 24596131 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-023382 (34 Act) Size: 114 KB |
Feb-05-2024 | 24593852 |
20-F | Document | Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001104659-24-008872 (34 Act) Size: 2004 KB |
Jan-31-2024 | 24583844 |
CERT | Document | Acc-no: 0001354457-24-000035 (34 Act) Size: 136 KB | Jan-26-2024 | 24563567 |
8-A12B | Document | Form for the registration / listing of a class of securities on a national securities exchange pursuant to section 12(b) Acc-no: 0001104659-24-006758 (34 Act) Size: 15 KB |
Jan-25-2024 | 24563298 |
425 | Document | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001104659-24-005669 ( Act) Size: 35 KB |
Jan-23-2024 | |
425 | Document | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001104659-24-004219 ( Act) Size: 5103 KB |
Jan-17-2024 | |
425 | Document | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001104659-23-118785 ( Act) Size: 22 KB |
Nov-15-2023 | |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001104659-23-118691 (33 Act) Size: 7526 KB |
Nov-15-2023 | 231410949 |
SEC STAFF LETTER | Document | Acc-no: 9999999997-23-004669 ( Act) Size: 62 KB | Nov-15-2023 | |
EFFECT | Document | Acc-no: 9999999995-23-003290 (33 Act) Size: 1 KB | Nov-13-2023 | 231401260 |
F-4/A | Document | Amendment to Registration statement for securities issued by foreign private issuers in certain business combination transactions Acc-no: 0001104659-23-117179 (33 Act) Size: 7583 KB |
Nov-13-2023 | 231398359 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001104659-23-116851 ( Act) Size: 6 KB |
Nov-13-2023 |
Recent 20 filings. View all PSYENCE BIOMEDICAL LTD. filings
Thanks I look forward to using the product to improve my skin tone
Very good communication and delivery made within the timeframe I was advised of
young lad who new his job ansered questions and new what was best for me.
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by